Locally advanced unresectable gastric cancer successfully resected after neoadjuvant chemotherapy with FADE regimen

Yonsei Med J. 1990 Mar;31(1):74-9. doi: 10.3349/ymj.1990.31.1.74.

Abstract

The prognosis of unresectable advanced gastric cancer is extremely poor. We tried a neoadjuvant chemotherapy in locally advanced unresectable stomach cancer diagnosed by initial explo-laparotomy. After chemotherapy with the FADE regimen (5-fluorouracil + adriamycin + cisplatin + etoposide), the patient was diagnosed clinically as a complete response state on re-staging with radiological gastrointestinal study, fiber-gastroscopy and computerized tomography. During the second-look operation, the advanced cancer was completely resected and the pathological diagnosis was early gastric cancer (EGC) type IIc, stage II (T1N2Mo).

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma / diagnostic imaging
  • Adenocarcinoma / drug therapy*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cisplatin / administration & dosage*
  • Combined Modality Therapy
  • Doxorubicin / administration & dosage*
  • Etoposide / administration & dosage*
  • Fluorouracil / administration & dosage*
  • Humans
  • Male
  • Middle Aged
  • Stomach / diagnostic imaging
  • Stomach / pathology
  • Stomach Neoplasms / diagnostic imaging
  • Stomach Neoplasms / drug therapy
  • Stomach Neoplasms / surgery*
  • Tomography, X-Ray Computed

Substances

  • Etoposide
  • Doxorubicin
  • Cisplatin
  • Fluorouracil